35 completed, 6 unknown, 5 not yet recruiting, 2 recruiting. 14 Phase 3, 8 Phase 2, 7 Not applicable, 6 Phase 4, 3 Phase 1.
Follow Mite Infestations: new trials by email Literature Review of Mite Infestations trials Research Report on Mite Infestations
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation ivermectin infant formula preparation, Standard ivermectin 3mg tablet - Scabies | Phase 1 | Suspended | Murdoch Childrens Research Institute | 52 | 2027-01-01 | 2026-10-09 |
| Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic Dermatitis Atopic Dermatitis (AD), Scabies | Not yet recruiting | Istanbul Medeniyet University | 51 | 2026-10-01 | 2026-09-15 | |
| Better Options for Lymphatic Filariasis Treatment MoxDA - Moxidectin + Diethylcarbamzine (DEC) + Albendazole, IDA - Ivermectin + DEC + albendazole - Lymphatic Filariasis, Scabies | Phase 3 | Recruiting | Medicines Development for Global Health | 5100 | 2026-09-28 | 2026-10-07 |
| Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers A mobile app with AI functionality for diagnosing skin-related NTDs - Skin and Connective Tissue Diseases, Neglected Tropical Diseases | Not applicable | Not yet recruiting | Kenya Medical Research Institute | 2420 | 2026-05-01 | 2026-04-02 |
| Comparison of Permethrin-Based Treatment Strategies Against Scabies in Infants and Young Children Permethrin 5% - Scabies | Early Phase 1 | Not yet recruiting | College of Physicians and Surgeons Pakistan | 68 | 2026-01-15 | 2026-02-03 |
| Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases Moxidectin, Ivermectin - Onchocerciasis, Ascaris Lumbricoides Infection | Phase 4 | Recruiting | Kirby Institute | 52000 | 2025-08-04 | 2025-11-21 |
| Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study) Ivermectin Tablets - Scabies; Itch, Scabies | Phase 2 | Active not recruiting | Murdoch Childrens Research Institute | 120 | 2025-06-24 | 2026-10-16 |
| Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies Permethrin Cream, 5%, Ivermectin 200 µg/kg - Scabies | Phase 2 | Not yet recruiting | Children Hospital and Institute of Child Health, Lahore | 90 | 2025-05-01 | 2025-04-20 |
| Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15) CHILD-IVITAB - Scabies | Phase 2 | Completed | University of Oxford | 13 | 2025-02-25 | 2025-12-18 |
| National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of Scabies data collection - Scabies | Completed | Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse | 1332 | 2025-01-07 | 2026-03-27 | |
| Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot Study Skin sampling - Scabies | Early Phase 1 | Unknown | Radboud University Medical Center | 144 | 2024-08-21 | 2024-08-09 |
| Sulfur 7% Cream Compared With Permethrin 5% Cream for Treating Scabies in Adults Sulfur 7% cream, Permethrin 5% cream - Scabies | Phase 4 | Completed | Can Tho University of Medicine and Pharmacy | 90 | 2024-06-01 | 2026-09-16 |
| Therapy for Scabies With Two Differently Concentrated Permethrin Creams 5% Permethrin Creme, 10% Permethrin Creme - Scabies | Phase 3 | Not yet recruiting | Infectopharm Arzneimittel GmbH | 220 | 2024-05-01 | 2024-04-23 |
| Efficacy and Safety Study of Moxidectin in Adults With Scabies Moxidectin Oral Product, Placebo - Scabies | Phase 2 | Completed | Medicines Development for Global Health | 200 | 2023-11-23 | 2026-06-16 |
| Ivermectin Safety in Small Children Oral ivermectin, Permethrin Cream, Placebo tablet - Scabies | Phase 2 | Completed | University of Oxford | 240 | 2023-11-18 | 2025-12-18 |
| Ivermectin/ Permethrin for Scabies Ivermectin Tablets, Permethrin Cream - Scabies | Phase 4 | Completed | Universitas Padjadjaran | 60 | 2023-01-25 | 2023-04-19 |
| Place of Hygiene in Scabies's Treatment in Populations in Precarious Situations Global management of scabies - Scabies | Not applicable | Unknown | Assistance Publique - Hôpitaux de Paris | 218 | 2022-04-01 | 2022-03-09 |
| Sulfur vs. Different Regimes of Permethrin for Scabies Permethrin Solution, Sulfur - Scabies | Phase 3 | Completed | Damascus University | 250 | 2022-03-15 | 2024-05-02 |
| PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies Spinosad Topical - Scabies | Phase 4 | Unknown | Cipher Pharmaceuticals Inc. | 50 | 2022-03-04 | 2025-02-14 |
| Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies Permethrin, Sulphur - Scabies | Phase 1 | Completed | Combined Military Hospital Abbottabad | 60 | 2022-03-01 | 2023-05-17 |
Showing 20 of 50. Sign in to see all of them.
Scabies (50) · Elephantiasis, Filarial (5) · Impetigo (4) · Neglected Diseases (4) · Pruritus (4) · Pyoderma (4) · Strongyloidiasis (3) · Yaws (3) · Communicable Diseases (2) · Onchocerciasis (2) · Parasitic Diseases (2) · Streptococcal Infections (2) · Ancylostomiasis (1) · Buruli Ulcer (1) · COVID-19 (1)
Ectoparasitic Infestations (50) · Infections (50) · Skin Diseases, Parasitic (50) · Skin Diseases (49) · Skin Diseases, Infectious (49) · Skin and Connective Tissue Diseases (49) · Parasitic Diseases (48) · Pathological Conditions, Signs and Symptoms (9) · Bacterial Infections and Mycoses (8) · Bacterial Infections (7) · Pathologic Processes (7) · Disease Attributes (6) · Filariasis (6) · Gram-Positive Bacterial Infections (6)
Ivermectin (13) · Permethrin (11) · Sulfur (3) · spinosad (3) · Albendazole (2) · Azithromycin (2) · Data Collection (2) · Suspensions (2) · Benzyl Alcohol (1) · Diethylcarbamazine (1) · Functional Status (1) · Tablets (1) · benzyl benzoate (1) · moxidectin (1)
London School of Hygiene and Tropical Medicine (4) · Medicines Development for Global Health (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Combined Military Hospital Abbottabad (2) · Infectopharm Arzneimittel GmbH (2) · Murdoch Childrens Research Institute (2) · ParaPRO LLC (2) · University of Oxford (2) · Assistance Publique - Hôpitaux de Paris (1) · B.P. Koirala Institute of Health Sciences (1) · Can Tho University of Medicine and Pharmacy (1) · Centre Hospitalier de Cayenne (1) · Centre de Recherche Médicale de Lambaréné (1) · Children Hospital and Institute of Child Health, Lahore (1) · Cipher Pharmaceuticals Inc. (1)
United States (10) · Fiji (5) · Pakistan (5) · Australia (3) · Dominican Republic (3) · El Salvador (3) · France (3) · Brazil (2) · Honduras (2) · Indonesia (2) · Kenya (2) · Puerto Rico (2) · Solomon Islands (2) · The Gambia (2) · Angola (1)
Kerry W Mettert, MBA (2) · Amanda Gwee (1) · Amanda Gwee, PhD (1) · Andrew Steer, PhD (1) · Anna R Last, MBChB PhD (1) · Armando Pineda-Velez, MD (1) · Ashis Patnaik, MD (1) · Bacha Kaoutar (1) · Bart Currie, MBBS, DTM&H (1) · Bruce Torkan, MD (1) · Bruneau Giraudeau, Doctor (1) · Christine Connors, MBBS (1) · Christopher King, MD PhD (1)
PMID 19936297, PMID 29985978, PMID 30252856, PMID 32589632, PMID 33728462, PMID 34758017, PMID 37419638, PMID 38735305, PMID 39109221, PMID 39551062, PMID 40378280, PMID 41494769
2019 (1), 2023 (1)